Why did CURN.SW stock fall pre-market today?

CURN.SW stock fell pre-market mainly due to thin liquidity and event-driven selling tied to clinical updates. Low average daily volume** (3,615.00)** magnifies price moves on trial news and trade flows on the SIX exchange.

What are the key ratios to watch for CURN.SW stock?

Key ratios include **EPS -0.84**, **PE -19.05**, **Price/Book 1.02**, and **current ratio 1.81**. These metrics show negative earnings, modest valuation versus book, and adequate short-term liquidity for the company.

What is Meyka AI's short-term forecast for CURN.SW stock?

Meyka AI's forecast model projects **monthly CHF 16.97** and **quarterly CHF 41.92**. The monthly forecast is roughly flat versus **CHF 16.90** current price, while the quarterly figure implies a large upside. Forecasts are model-based and not guarantees.

Should investors treat the Meyka grade as a buy signal for CURN.SW stock?

Meyka AI rates CURN.SW **65.11** (Grade B, HOLD). This grade summarizes metrics and forecasts but is not a buy recommendation. Investors should combine it with due diligence and consider pipeline risk and liquidity on the SIX market.

CH Stocks

Pre-market top loser CURN.SW Curatis Holding AG down 5.33% 12 Feb 2026: catalysts

ByHuzaifa Zahoor February 12, 2026

CURN.SW stock opened the pre-market session as a top loser after an intraday swing left the price at CHF 16.90 on 12 Feb 2026. The move follows a reported one-day decline of 5.33%, with volume at 4,342 shares versus a 50-day average of 3,615.00. Traders cite clinical trial updates and thin liquidity on the SIX exchange in Switzerland as the likely drivers behind the early weakness.